David McConkey

发表

A phase I surrogate endpoint study of SU6668 in patients with solid tumors

Edward F. Jackson, Kenneth Hess, James L. Abbruzzese, 2004, Investigational New Drugs.

miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy

Woonyoung Choi, Liana Adam, G. Calin, 2009, Clinical Cancer Research.